Skip to main content
Clinical Trials/IRCT20221016056204N1
IRCT20221016056204N1CompletedUnknown

The effectiveness of applying Mobile-Health Technology to manage modifiable risk factors of coronary artery disease for secondary prevention: a randomized clinical trial

Tehran University of Medical Sciences0 sites1,544 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Unknown
Status
Completed
Enrollment
1,544

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
25 years to 75 years (—)
Sex
All

Inclusion Criteria

  • History of CAD defined as history of myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft surgery, coronary angiography confirming stenosis>50% in at least one of the major epicardial coronary arteries or their main branches.
  • Having at least one uncontrolled risk factor including: uncontrolled hypertension, uncontrolled dyslipidemia and current cigarette smoking for =12 months.
  • Aged between 25 to 75 years
  • Inclination to staying in study for two years
  • Having and ability of using smart phone by the participant or one of his/her trustworthy relatives who lives near him/her
  • Willing to control the risk factors using App
  • Provides informed consent to participate in the study

Exclusion Criteria

  • Mental retardation
  • Individuals with prohibitive morbidity that requires close face-to-face monitoring.
  • End stage chronic disease such as: hepatic and/or renal failure, heart failure, active cancer

Investigators

Similar Trials